<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637571</url>
  </required_header>
  <id_info>
    <org_study_id>201102718</org_study_id>
    <nct_id>NCT01637571</nct_id>
  </id_info>
  <brief_title>Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain</brief_title>
  <acronym>Dexilant</acronym>
  <official_title>The Effect of Dexilant Treatment on Esophageal Hypersensitivity in GERD Related Non Cardiac Chest Pain Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate a new treatment for non-cardiac chest pain (NCCP)
      related to gastrointestinal reflux disease (GERD), called Dexilant. The investigators would
      like to test its effectiveness in treating NCCP.

      The patient will undergo esophageal balloon distention testing (EBDT) before and after taking
      the new treatment for one month (Dexilant). EBDT evaluates the sensation and mechanical
      properties of the esophagus. A catheter with a deflated balloon is placed through the mouth
      and into the esophagus and the balloon is inflated with water. ECG and labs will be done
      throughout the study as a measurement of safety.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Sponsor could not fund
  </why_stopped>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of chest pain episodes in treatment vs placebo groups</measure>
    <time_frame>12 weeks</time_frame>
    <description>the number of chest pain episodes during the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensity of chest pain episodes</measure>
    <time_frame>12 weeks</time_frame>
    <description>how strong the chest pain episodes are</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory thresholds for first sensation</measure>
    <time_frame>12 weeks</time_frame>
    <description>the balloon distension level when a sensation is first felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory thresholds for discomfort</measure>
    <time_frame>12 weeks</time_frame>
    <description>the balloon distension level when discomfort is felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory thresholds for pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>the balloon distension level when pain is felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of chest pain episodes</measure>
    <time_frame>12 weeks</time_frame>
    <description>how long the chest pain episodes last</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Chest Pain</condition>
  <condition>Gastrointestinal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Dexilant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>60mg of Dexilant QD for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>60mg of Dexilant placebo QD for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexilant</intervention_name>
    <description>60mg of Dexilant QD for 12 weeks</description>
    <arm_group_label>Dexilant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexilant Placebo</intervention_name>
    <description>60mg of Dexilant placebo QD for 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Dexlansoprazole</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 18-75 years

          2. NERD, or GERD LA Class A-B (endoscopy)

          3. Subjects with positive pH testing

          4. At least one episode of chest pain a week in the past month

          5. Previous negative cardiac evaluation (EKG ± stress test ± coronary angiogram)

          6. Negative esophageal evaluation for a motility disorder (Nutcracker esophagus,
             achalasia)

        Exclusion Criteria:

          1. Subjects requiring narcotics or other pain medications, Subjects with known LA class
             C-D, Barrett's esophagus or peptic stricture on endoscopy

          2. Subjects with previous upper gastrointestinal surgery

          3. Pregnancy

          4. Subjects with diabetes, neuromuscular disorders, or other severe co-morbidities

          5. (Cardiovascular, respiratory, renal, hepatic, hematologic, endocrine, neurologic, and
             psychiatric).

          6. Subjects with upper airway symptoms (such as hoarseness, wheezing, laryngospasm).

          7. Medications such as baclofen, and prokinetic agents.

          8. History of substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Schey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2011</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2012</study_first_posted>
  <last_update_submitted>July 10, 2012</last_update_submitted>
  <last_update_submitted_qc>July 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>NCCP</keyword>
  <keyword>chest pain</keyword>
  <keyword>reflux</keyword>
  <keyword>GERD related non-cardiac chest pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
    <mesh_term>Esophagitis, Peptic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexlansoprazole</mesh_term>
    <mesh_term>Lansoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

